Skip to main navigation
Compass Therapeutics
  • Home
  • About
  • Platform
  • Pipeline
  • Clinical Trials
  • Join Us
  • Investors
  • Contact

News Releases

Investor Menu
  • Home
  • News & Events
    • News Releases
    • Events
    • Presentations
    • In the News
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial & FIlings
    • SEC Filings
    • Annual Meeting
    • Annual Reports
    • Quarterly Results
Jun 01, 2023
Compass Therapeutics to Participate in Upcoming Investor Events
Additional Formats
PDF Version
May 04, 2023
Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
Additional Formats
PDF Version
Apr 26, 2023
Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ
Additional Formats
PDF Version
Apr 19, 2023
Compass Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
Additional Formats
PDF Version
Mar 28, 2023
Compass Therapeutics to Participate in the Cantor Fitzgerald Future of Oncology Symposium
Additional Formats
PDF Version
Mar 15, 2023
Compass Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Additional Formats
PDF Version
Feb 02, 2023
Compass Therapeutics to Participate in the SVB Securities Global Biopharma Conference
Additional Formats
PDF Version
Jan 19, 2023
Compass Therapeutics Announces that the Phase 2 Data of CTX-009 in Combination with Paclitaxel in Patients with Biliary Tract Cancers (BTC) will be Presented at the ASCO GI Cancers Symposium on January 20, 2023
Additional Formats
PDF Version
Jan 06, 2023
Compass Therapeutics Announces First Patient Dosed in the Phase 2 U.S. Study of CTX-009 in Patients with Metastatic Colorectal Cancer
Additional Formats
PDF Version

IR Contact

IR@compasstherapeutics.com

Media Contact

Anna Gifford, Communications Manager

Anna.Gifford@compasstherapeutics.com

Email Alerts

  • © 2023 Compass Therapeutics, Inc.
  • Terms & Conditions
  • Privacy Policy
  • Home
  • About
  • Platform
  • Pipeline
  • Clinical Trials
  • Join Us
  • Investors
  • Contact